Health Condition 1: 4- Measurement and Monitoring
Conditions
Interventions
Intervention1: Preventive medication: Inj. dexamethasone 0.1mg/kg,Inj. Ondansetron4mg after giving spinal anaesthesia
Control Intervention1: Inj. Dexamethasone0.1 mg/ kg: Inj. Dexamethasone 0.1mg/kg i
Sponsors
Dr Irene C John
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age group 21 – 60yrs 2)Willing to participate in the study 3) ASA1 , ASA2 4)undergoing elective cesarean and urological surgeries.
Exclusion criteria
Exclusion criteria: Patients refusing consent. Emergency surgery and day care surgeries patients taking one of the studied drugs (ondansetron or dexamethasone) Patients with Dementia, substance abuse, neurologic or seizure disorder, muscular disorder, coagulopathy, severe hepatic and renal impairment, history of allergy to local anaesthetics, previous back surgery, infection or mass at the site of injection and vertebral column deformity, history of peptic ulcer, diabetes mellitus and hypothyroidism Uncooperative and unwilling patients Patients having fever or hypothermia or requiring blood transfusion and operations more than two hours. Impaired cardiovascular status
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall incidence of shiveringTimepoint: 0min, 30min, 1 hour, 2 hour,3 hour,4hour | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset of shivering after inductionTimepoint: 0min, 30min, 1 hour, 2 hour,3 hour,4hour;Severity of shiveringTimepoint: Tsai & Chu grading scale: grade 0, grade1, grade2, grade3, grade4;Incidence of thermoregulatory & non thermoregulatory shiveringTimepoint: 0min, 30min, 1 hour, 2 hour,3 hour,4hour;Incidence of side effects such as hypotension, bradycardia, respiratory depression, pruritis.Timepoint: 0min, 30min, 1 hour, 2 hour,3 hour,4hour | — |
Countries
India
Contacts
Public ContactDr Rajesh Kumar Kodali V
Sri Ramachandra Institute of Higher Education and Research
Outcome results
None listed